24 Results

People

  1. Nimer
    Nimer
  2. Kewalramani
    Kewalramani
  3. Moskowitz
    Moskowitz
  4. Zelenetz
    Zelenetz
  5. Yahalom
    Yahalom
  6. Klimek
    Klimek
  7. Portlock
    Portlock
  8. Comenzo
    Comenzo
  9. Fleisher
    Fleisher
  10. Hassoun
    Hassoun

Groups

  1. Center for Hematologic Malignancies (24)
  2. Department of Medicine (24)
  3. Hematologic Malignancies, Division of (24)
  4. Lymphoma (12)
  5. Survivorship Research (11)
  6. Adult Leukemia (10)
  7. Radiation Oncology, Department of (9)
  8. Nursing (7)
  9. Myeloma (5)
  10. Biostatistics Service (4)
  1. "aged"
  2. "Center for Hematologic Malignancies"
  3. "Stephen Nimer"
Formats
  1. Journal Article (24)
Groups
  1. Center for Hematologic Malignancies (24)
  2. Department of Medicine (24)
  3. Hematologic Malignancies, Division of (24)
  4. Lymphoma (12)
  5. Survivorship Research (11)
  6. Adult Leukemia (10)

More Groups

People
  1. Stephen Nimer (24)
  2. Andrew Zelenetz (12)
  3. Craig Moskowitz (12)
  4. Tarun Kewalramani (12)
  5. Joachim Yahalom (9)
  6. Julie Feldstein (8)

More People

Years
  1. 2012 (4)
  2. 2010 (1)
  3. 2008 (2)
  4. 2007 (2)
  5. 2006 (5)
  6. 2005 (2)

More Years

Publications
  1. Blood (7)
  2. British Journal of Haematology (4)
  3. Annals of Oncology (2)
  4. Bone Marrow Transplantation (2)
  5. Journal of Clinical Oncology (2)
  6. Leukemia (2)

More Publications

Publishers
  1. American Society of Hematology (7)
  2. John Wiley & Sons (4)
  3. Nature Publishing Group (4)
  4. American Society of Clinical Oncology (2)
  5. Elsevier Ltd (2)
  6. Oxford University Press (2)

More Publishers

Results (24)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Efficacy of hypomethylating agents in therapy-related myelodysplastic syndromes
    Journal Article

    Klimek, V. M.; Dolezal, E. K.; Tees, M. T.; Devlin, S. M.; Stein, K.; Romero, A.; Nimer, S. D.
    Leukemia Research (2012)

    Fulltext@MSK | Save
  • Normalization of pre-ASCT, FDG-PET imaging with second-line, non-cross-resistant, chemotherapy programs improves event-free survival in patients with Hodgkin lymphoma
    Journal Article

    Moskowitz, C. H.; Matasar, M. J.; Zelenetz, A. D.; Nimer, S. D.; Gerecitano, J.; Hamlin, P.; Horwitz, S.; Moskowitz, A. J.; Noy, A.; Palomba, L.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • Phase I trial of sodium salicylate in patients with myelodysplastic syndromes and acute myelogenous leukemia
    Journal Article

    Klimek, V. M.; Dolezal, E. K.; Smith, L.; Soff, G.; Nimer, S. D.
    Leukemia Research (2012)

    Fulltext@MSK | Save
  • Bortezomib, liposomal doxorubicin and dexamethasone followed by thalidomide and dexamethasone is an effective treatment for patients with newly diagnosed multiple myeloma with Internatinal Staging System stage II or III, or extramedullary disease
    Journal Article

    Landau, H.; Pandit-Taskar, N.; Hassoun, H.; Cohen, A.; Lesokhin, A.; Lendvai, N.; Drullinsky, P.; Schulman, P.; Jhanwar, S.; Hoover, E.; more...
    Leukemia and Lymphoma (2012)

    Fulltext@MSK | Save
  • High-dose chemo-radiotherapy for relapsed or refractory Hodgkin lymphoma and the significance of pre-transplant functional imaging: Research paper
    Journal Article

    Moskowitz, C. H.; Yahalom, J.; Zelenetz, A. D.; Zhang, Z.; Filippa, D.; Teruya-Feldstein, J.; Kewalramani, T.; Moskowitz, A. J.; Rice, R.; Maragulia, J.; more...
    British Journal of Haematology (2010)

    Fulltext@MSK | Save
  • CD32B is highly expressed on clonal plasma cells from patients with systemic light-chain amyloidosis and provides a target for monoclonal antibody-based therapy
    Journal Article

    Zhou, P.; Comenzo, R. L.; Olshen, A. B.; Bonvini, E.; Koenig, S.; Maslak, P. G.; Fleisher, M.; Hoffman, J.; Jhanwar, S.; Young, J. W.; more...
    Blood (2008)

    Fulltext@MSK | Save
  • Tolerability, pharmacodynamics, and pharmacokinetics studies of depsipeptide (Romidepsin) in patients with acute myelogenous leukemia or advanced myelodysplastic syndromes
    Journal Article

    Klimek, V. M.; Fircanis, S.; Maslak, P.; Guernah, I.; Baum, M.; Wu, N.; Panageas, K.; Wright, J. J.; Pandolfi, P. P.; Nimer, S. D.
    Clinical Cancer Research (2008)

    Fulltext@MSK | Save
  • Maintaining the dose intensity of ICE chemotherapy with a thrombopoietic agent, PEG-rHuMGDF, may confer a survival advantage in relapsed and refractory aggressive non-Hodgkin lymphoma
    Journal Article

    Moskowitz, C. H.; Hamlin, P. A.; Gabrilove, J.; Bertino, J. R.; Portlock, C. S.; Straus, D. J.; Gencarelli, A. N.; Nimer, S. D.; Zelenetz, A. D.
    Annals of Oncology (2007)

    Fulltext@MSK | Save
  • Risk-adapted autologous stem cell transplantation with adjuvant dexamethasone ± thalidomide for systemic light-chain amyloidosis: Results of a phase II trial
    Journal Article

    Cohen, A. D.; Zhou, P.; Chou, J.; Teruya-Feldstein, J.; Reich, L.; Hassoun, H.; Levine, B.; Filippa, D. A.; Riedel, E.; Kewalramani, T.; more...
    British Journal of Haematology (2007)

    Fulltext@MSK | Save
  • Pilot study of combination transcriptional modulation therapy with sodium phenylbutyrate and 5-azacytidine in patients with acute myeloid leukemia or myelodysplastic syndrome
    Journal Article

    Maslak, P.; Chanel, S.; Camacho, L. H.; Soignet, S.; Pandolfi, P. P.; Guernah, I.; Warrell, R.; Nimer, S.
    Leukemia (2006)

    Fulltext@MSK | Save